Dyne Therapeutics Net Income

Dyne Therapeutics (DYN) currently reports a net income of $-600M as of September 2026. That compares with $-420M in the prior-year period — down 42.7% year over year. That is below the Healthcare sector average of $1.5T. Use the charts on this page to explore Dyne Therapeutics's net income history and peer comparisons.

Dyne Therapeutics's net income decreased from $-420M to $-600M — a 42.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dyne Therapeutics's net income of $-600M is lower than the Healthcare sector average of $1.5T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Dyne Therapeutics reported $-600M in net income as of September 2026. That compares with $-420M in the prior-year period — down 42.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-600M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $1.5T. From there, open related valuation or income-statement pages for Dyne Therapeutics, and consider following DYN for alerts when major investors trade the stock.